(Click the image above for more information about the event and participating companies)
| KEYNOTES & JAPANESE COMPANY PITCHES |
REGISTER FOR |
B2B MEETINGS WITH JAPANESE COMPANIES |
|
Wednesday-Thursday July 14-15, 2021 ブラック クイーン ブラック ジャック - 6:30 PM PDT |
Deadline: Tuesday, July 13, 2021 ブラック クイーン ブラック ジャック PM PDT |
Please contact Japanese companies via the E-mail listed to arrange a meeting |
Pitch Session
Thursday, July 15, 2021
Hisanori Matsui, PhD. Neuroscience Pipeline Sustainability & Partnership |
Takeda Pharmaceutical Company Limited
Takeda is a patient-focused, values-based, R&D-driven global biopharmaceutical company with 240 years of history. Neuroscience is a core therapeutic area for Takeda. Our focused diseases are age-related neurological disorders, hereditary neurological disorders and neuromuscular disorders. We need innovation enablers which include brain and muscle shuttle/delivery, patient segmentation and disease classification, and human-based Neuroscience research platform. From the initial idea to the launch of the medicine we are committed to working in partnership with external experts who share our vision and possess the knowledge and scientific capabilities to make truly transformative medicines for the patients we serve.
Takeda HP / LinkedIn / Twitter / YouTube
|
